To determine whether the observed SMAD4-dependent alterations in cytokine and chemokine production correspond to changes in T-cell activation, we again utilized PANC-1 tumor cells, which were incubated with either a control siRNA (siControl) or siRNA against SMAD4 (siSMAD4). The gene discussed is SMAD4; the disease is neoplasm.